Literature DB >> 11082128

The pharmacology of nucleotide receptors on primary rat brain endothelial cells grown on a biological extracellular matrix: effects on intracellular calcium concentration.

I Sipos1, E Dömötör, N J Abbott, V Adam-Vizi.   

Abstract

1. Brain capillary endothelial cells express a variety of nucleotide receptors, but differences have been reported between culture models. This study reports examination of nucleotide receptors on primary cultured rat brain capillary endothelial cells (RBCEC) grown on a biological extracellular matrix (ECM) to produce a more differentiated phenotype. 2. Fura-2 fluorescence ratio imaging was used to monitor intracellular free calcium concentration [Ca(2+)](i). ATP, UTP, and 2-methylthioATP (2-MeSATP) increased [Ca(2+)](i) to similar levels, while 2-MeSADP, ADP and adenosine gave smaller responses. 3. Removal of extracellular calcium caused no significant change in the [Ca(2+)](i) response to 2-MeSATP, evidence that the response was mediated by a metabotropic (P2Y) receptor. 4. All cells tested responded to ATP, UTP, 2-MeSATP and ADP, while 63% responded to adenosine and 50% to 2-MeSADP. No cells responded to alpha, beta-methyleneATP. Cells grown on rat tail collagen instead of ECM gave smaller and less uniform [Ca(2+)](i) responses, suggesting that the differentiating effect of the ECM contributed to a more uniform receptor profile. 5. The [Ca(2+)](i) response to the P2Y(1)-selective agonist 2-MeSADP was abolished in the presence of the subtype-selective antagonist adenosine 3'-phosphate 5'-phosphosulphate (PAPS). 6. The P2Y(2) antagonist suramin completely blocked the response to ATP and inhibited the response to UTP by 66%. 7. The A(1) subtype-selective adenosine receptor agonist N(6)-Cyclopentyladenosine (CPA) gave a small but characteristic [Ca(2+)](i) response, while A(2A) and A(2B) subtype-selective agonists failed to generate [Ca(2+)](i) changes. 8. The results are consistent with the presence on RBCEC of a P2Y(2)-like receptor coupled to phospholipase C, and a P2Y(1)-like receptor mobilizing intracellular Ca(2+). The role of multiple nucleotide receptors in the function of the brain endothelium is discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11082128      PMCID: PMC1572433          DOI: 10.1038/sj.bjp.0703675

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  54 in total

1.  Understanding the Physiology of the Blood-Brain Barrier: In Vitro Models.

Authors:  Gerald A. Grant; N. Joan Abbott; Damir Janigro
Journal:  News Physiol Sci       Date:  1998-12

2.  PPADS inhibits P2Y1 purinoceptors in rat brain capillary endothelial cells and in rat ileal myocytes by an indirect mechanism.

Authors:  P Vigne; P Pacaud; G Loirand; J P Breittmayer; C Frelin
Journal:  Biochem Biophys Res Commun       Date:  1998-03-17       Impact factor: 3.575

3.  Preparation of glial extracellular matrix: a novel method to analyze glial-endothelial cell interaction.

Authors:  H Mizuguchi; N Utoguchi; T Mayumi
Journal:  Brain Res Brain Res Protoc       Date:  1997-10

4.  Towards a revised nomenclature for P1 and P2 receptors.

Authors:  B B Fredholm; M P Abbracchio; G Burnstock; G R Dubyak; T K Harden; K A Jacobson; U Schwabe; M Williams
Journal:  Trends Pharmacol Sci       Date:  1997-03       Impact factor: 14.819

5.  An electrophysiological study of microvascular permeability and its modulation by chemical mediators.

Authors:  S P Olesen
Journal:  Acta Physiol Scand Suppl       Date:  1989

6.  Diadenosine polyphosphates as antagonists of the endogenous P2Y(1) receptor in rat brain capillary endothelial cells of the B7 and B10 clones.

Authors:  P Vigne; J P Breittmayer; C Frelin
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

7.  Characterization of P2 receptors for purine and pyrimidine nucleotides in human placental cotyledons.

Authors:  V Ralevic; S Burrell; J Kingdom; G Burnstock
Journal:  Br J Pharmacol       Date:  1997-07       Impact factor: 8.739

Review 8.  Inflammatory mediators and modulation of blood-brain barrier permeability.

Authors:  N J Abbott
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

9.  Regulation of cyclic AMP by extracellular ATP in cultured brain capillary endothelial cells.

Authors:  Z Anwar; J L Albert; S E Gubby; J P Boyle; J A Roberts; T E Webb; M R Boarder
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

10.  On the suitability of adenosine 3'-phosphate 5'-phosphosulphate as a selective P2Y receptor antagonist in intact tissues.

Authors:  R Bültmann; F Tuluc; K Starke
Journal:  Eur J Pharmacol       Date:  1998-06-19       Impact factor: 4.432

View more
  5 in total

1.  Ca(2+)- and voltage-dependent gating of Ca(2+)- and ATP-sensitive cationic channels in brain capillary endothelium.

Authors:  László Csanády; Vera Adam-Vizi
Journal:  Biophys J       Date:  2003-07       Impact factor: 4.033

2.  Purine receptors and Ca(2+) signalling in the human blood-brain barrier endothelial cell line hCMEC/D3.

Authors:  Willem Bintig; Daniela Begandt; Barbara Schlingmann; Linda Gerhard; Maria Pangalos; Lutz Dreyer; Natalija Hohnjec; Pierre-Olivier Couraud; Ignacio A Romero; Babette B Weksler; Anaclet Ngezahayo
Journal:  Purinergic Signal       Date:  2011-09-29       Impact factor: 3.765

Review 3.  Dynamics of CNS barriers: evolution, differentiation, and modulation.

Authors:  N Joan Abbott
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

Review 4.  Astrocyte-endothelial interactions and blood-brain barrier permeability.

Authors:  N Joan Abbott
Journal:  J Anat       Date:  2002-06       Impact factor: 2.610

5.  Multifunctional Liposomes Modulate Purinergic Receptor-Induced Calcium Wave in Cerebral Microvascular Endothelial Cells and Astrocytes: New Insights for Alzheimer's disease.

Authors:  Greta Forcaia; Beatrice Formicola; Giulia Terribile; Sharon Negri; Dmitry Lim; Gerardo Biella; Francesca Re; Francesco Moccia; Giulio Sancini
Journal:  Mol Neurobiol       Date:  2021-01-29       Impact factor: 5.590

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.